Internal Medicine
RSSArticles
-
Finally, a Positive Outcomes Study for Platelet Function Testing
Platelet function testing-defined clopidogrel nonresponsiveness can be overcome by prasugrel treatment, and that this is a modifiable risk factor whose treatment can improve outcomes.
-
Slow Down, Save Lives? Rate Control in Atrial Fibrillation
Atrial fibrillation patients receiving beta-blockers or calcium channel blockers had lower risk of mortality compared to those not taking rate-control drugs, with the lowest mortality rate in the beta-blocker group, while digoxin use was associated with a higher risk of mortality.
-
Beta-blocker Dose More Important Than Heart Rate in Systolic Heart Failure
In chronic heart failure with reduced ejection fraction, titrating beta-blocker doses may confer a greater benefit than reducing heart rate.
-
Reduced Leaflet Motion in Bioprosthetic Valves
ABSTRACT & COMMENTARY: It's in a significant proportion of surgical and transcatheter bioprosthetic aortic valves by volume-rendered CT scans.
-
ECG Review: A 43-Year-Old Man with Atypical Chest Pain
-
Clinical Briefs
In this section: reversing the anticoagulant effect of dabigatran; considering the likelihood of occult cancer causing unprovoked deep venous thrombosis; and cardiovascular autonomic neuropathy occurs earlier in type 2 diabetes.
-
Evolocumab Injection (Repatha)
Evolocumab is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-C.
-
Vitamin D and Diabetic Neuropathy
Vitamin D deficiency may exacerbate the clinical manifestations of diabetic neuropathy, and supplementation with vitamin D3 may be beneficial.
-
Nutrition Therapy for Hypertension Using the Nitric Oxide Pathway
Daily one-time ingestion of inorganic nitrate from beet juice consistently lowered blood pressure in hypertensive patients by an amount comparable to single-drug therapy.
-
Intensification of Oral Therapy for Type 2 Diabetes
ABSTRACT & COMMENTARY: It may not be relevant to primary care physicians. Here's why.